--- title: 'Industry Daily Summary: What Happened on October 26, 2026' headline: Nuclera names Carl Raimond CEO description: Co-founder Michael Chen takes the chief scientific and business officer role. url: https://thebench.bio/news/industry/2026-10-26 topic: industry date: '2026-10-26' covers: - '2026-10-26' date_published: '2026-10-26T12:05:39Z' date_modified: '2026-10-26T12:05:39Z' tags: - Industry sources: 1 publisher: TheBench.Bio --- # Industry Daily Summary: What Happened on October 26, 2026 **Nuclera names Carl Raimond CEO** Co-founder Michael Chen takes the chief scientific and business officer role. ## Today in brief Carl Raimond became Nuclera’s chief executive immediately, succeeding co-founder Michael Chen. [1] ## Leadership change Chen, Nuclera’s former CEO, became chief scientific and business officer. [1] The company said the appointments combine Raimond’s experience growing life-sciences businesses with Chen’s scientific leadership and knowledge of Nuclera’s technology and markets. [1] ## Also published - [Defining One Value-Creating, Stock-Moving Catalyst For 10 Different Companies](), Matt Gamber - [31st Edition Strategic Project & Portfolio Management for Pharma](), pharmaphorum - [The Ron Lanton Report: A Conversation with Dr. Nadine Zawadzki](), BioPharm International - [The Importance of Reframing COVID-19 as a Preventable Event](), Pharmaceutical Executive - [The molecule was fine. The moment wasn’t.](), BioPharma Dive - [UK puts £100m into "world-first" AI biosecurity facility](), pharmaphorum ## Sources 1. [Raimond takes helm at Nuclera](), Pharmafile, 2026-10-26 --- TheBench.Bio wrote this from the reporting cited above, with a language model drafting and editing. [1]: